Results 131 to 140 of about 28,931 (239)

Final adult height in male patients with central precocious puberty after gonadotropin-releasing hormone agonist treatment. [PDF]

Ann Pediatr Endocrinol Metab
Cho KW, Kim YK, Yoo JE, Kim JY, Kim SJ, Kim S, Choi Y, Song K, Lee EB, Chae HW, Suh J.   +10 more
europepmc   +1 more source

The effects of gonadotropin-releasing hormone agonist on final adult height among girls with early and fast puberty. [PDF]

Front Endocrinol (Lausanne), 2023
Tseng CH, Lee YJ, Huang CY, Wu YL, Wang LT, Lin CH, Cheng BW, Lo FS, Chang YJ, Ting WH.   +9 more
europepmc   +1 more source

Analysis of the benefit of gonadotropin-releasing hormone agonist treatment in premenopausal women undergoing hematopoietic cell transplantation. [PDF]

Sci Rep, 2023
Han R, Song Z, Li H, Wang C, Zhang L, Yang X.   +5 more
europepmc   +1 more source

Impact of MED12 mutation and CDK8 activity on uterine leiomyoma growth and response to gonadotropin-releasing hormone agonist treatment. [PDF]

PLoS One
Tanioka S, Asano R, Ota Y, Nagai K, Takenaka K, Mizushima T, Miyagi Y, Miyagi E.   +7 more
europepmc   +1 more source

Long-acting gonadotropin-releasing hormone agonist trigger in fertility preservation cycles before chemotherapy. [PDF]

ESMO Open, 2023
Massarotti C, Stigliani S, Gazzo I, Lambertini M, Anserini P.   +4 more
europepmc   +1 more source

Outcomes of Patients With Familial Central Precocious Puberty due to Mutations of <i>MKRN3</i> Gene After Treatment With Gonadotropin-Releasing Hormone Agonist. [PDF]

Int J Endocrinol
Chen Z, Li W, Wang J, Dong Z, Li C, Wang W, Hu R, Ma X, Xiao Y, Lu W.   +9 more
europepmc   +1 more source

Immunoreactive inhibin in human follicular fluid in an ovarian hyperstimulation proramme for in vitro fertilisation: correlations and different forms [PDF]

, 1993
Lechner, K., Mehltretter, G., Müller, O. A., Reichardt, Bärbel, Rjosk, H. K., Schopohl, J.   +5 more
core   +1 more source

Gonadotropin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction. [PDF]

Cochrane Database Syst Rev
Siristatidis CS, Yong LN, Maheshwari A, Ray Chaudhuri Bhatta S.   +3 more
europepmc   +1 more source

Luteal phase support with gonadotropin-releasing hormone agonist

Journal of the Chinese Medical Association, 2014
Tsui, Kuan-Hao, Lin, Li-Te, Wang, Peng-Hui   +2 more
openaire   +2 more sources

Pituitary Apoplexy Following Gonadotropin-Releasing Hormone Agonist Therapy: A Rare and Life-Threatening Complication. [PDF]

Cureus
Naghiyeva A, Smati N, Lucas CG, Page BR, Zilbermint M.   +4 more
europepmc   +1 more source